Company Profile

Omnisite Biodiagnostics Inc (AKA: Zoeic Technologies Inc)
Profile last edited on: 10/29/2020      CAGE: 1RZ83      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1999
First Award
2000
Latest Award
2005
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

101 West Sixth Street
Austin, TX 78727
   (512) 479-7732
   nnoster@spec.com
   www.spec.com/omnisite
Location: Single
Congr. District: 37
County: Travis

Public Profile

Originally spun-off from Systems & Processes Engineering (SPEC), OmniSite is developing a handheld reader with disposable test cartridges for point-of-care testing on a single drop of blood. The firm plans teaming arrangements with several major pharamceutical and diagnostic companies for the development, manufacture and distribution of various instruments

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
75-99
Revenue Range
7.5M-10M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2005 1 USDA $80,000
Project Title: Rapid Pen Side Diagnostic Test for Classical Swine Fever
2004 2 Navy $592,990
Project Title: Handheld Chemical/Biological (CB) Aptamer-Based ECL Point Detection Sensor (AEPDS)
2003 1 NASA $75,000
Project Title: FRET Aptamer-Based Glucose Sensor for the Rotating Space BioReactor
2003 1 Army $69,995
Project Title: DNA Aptamer Induction of Anthrax Germination
2002 1 OSD $99,997
Project Title: Handheld FP Reader and Aptamer Tests for Soft Tissue Injury

Key People / Management

  Scott Combs -- President

  John G Bruno -- Chief Technical Officer

  Austin F Sequeira

  Sydney J Ulvick

Company News

There are no news available.